Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Aug 11, 2026
JOET vs SPY: Quality Momentum Strategy Meets Broad Market Benchmark

JOET vs SPY: Quality Momentum Strategy Meets Broad Market Benchmark

Key Takeaways

  • Virtus Terranova U.S. Quality Momentum ETF (JOET) employs a factor-based strategy targeting quality and momentum characteristics in large-cap U.S. stocks, while State Street SPDR S&P 500 ETF Trust (SPY) provides broad, market-cap-weighted exposure to the S&P 500 Index.
  • JOET holds approximately 125 securities with roughly equal weighting among selected names, resulting in a more concentrated thematic tilt compared to SPY’s roughly 500 holdings.
  • JOET carries an expense ratio of 0.29%, higher than SPY’s 0.09%, reflecting the costs associated with its active factor screening and rebalancing process.
  • Sector allocations differ notably, with JOET showing elevated exposure to technology and industrials relative to SPY’s heavier weighting in mega-cap technology names.
  • JOET’s momentum overlay can lead to greater sensitivity to short-term trend shifts, whereas SPY delivers more stable representation of overall large-cap market performance across market cycles.
  • Both ETFs target U.S. large-cap equities but serve distinct investor objectives: factor-enhanced returns versus core benchmark tracking.

Introduction

Investors seeking U.S. large-cap equity exposure often weigh broad market benchmarks against factor-driven alternatives. Virtus Terranova U.S. Quality Momentum ETF (JOET) and State Street SPDR S&P 500 ETF Trust (SPY) both provide access to prominent U.S. companies yet pursue different methodologies. JOET applies quantitative screens for quality and momentum, while SPY replicates the widely followed S&P 500 Index. The comparison helps clarify structural trade-offs in cost, diversification, and potential performance drivers within the current large-cap environment. I also checked this using Tickeron’s AI Screener to see how the two line up on key metrics.

Understanding JOET’s Factor Approach

Virtus Terranova U.S. Quality Momentum ETF (JOET) tracks the Terranova U.S. Quality Momentum Index, a rules-based benchmark that selects large-capitalization U.S. stocks exhibiting strong quality fundamentals and positive price momentum. The fund maintains approximately 125 holdings, with individual positions typically weighted near 0.9 percent. Top holdings include names such as Amazon.com Inc., Garmin Ltd., Corning Inc., Quanta Services Inc., and First Solar Inc. Sector exposures emphasize technology (around 27 percent), industrials (around 17 percent), and financial services (around 15 percent). The ETF carries an expense ratio of 0.29 percent and follows a passive index methodology with periodic rebalancing to maintain factor characteristics. This structure distinguishes JOET from traditional market-cap approaches by incorporating systematic quality and momentum filters.

SPY: The Benchmark Standard

State Street SPDR S&P 500 ETF Trust (SPY) seeks to replicate the performance of the S&P 500 Index before expenses. The fund holds approximately 500 securities and employs market-capitalization weighting. Top holdings are dominated by large technology companies, including NVIDIA Corporation, Microsoft Corporation, and Apple Inc. Sector allocations feature technology at roughly 37 percent, followed by financial services and communication services. SPY maintains an expense ratio of 0.09 percent, reflecting its low-cost, passive structure as a unit investment trust. Rebalancing occurs as needed to align with index changes. The ETF’s high liquidity and broad representation of the U.S. large-cap market make it a core holding for many portfolios.

Broader Market Environment

Both ETFs operate within the U.S. large-cap equity space, which continues to be influenced by technological innovation, corporate earnings cycles, and monetary policy expectations. Capital flows into growth-oriented sectors remain prominent, supported by advancements in artificial intelligence and digital infrastructure. Regulatory developments around antitrust and data privacy affect major technology constituents. Macroeconomic drivers, including interest rate paths and inflation trends, influence sector rotation between growth and value segments. Risks include valuation compression in high-multiple names and potential slowdowns in earnings momentum for cyclical industries.

How They Stack Up in Performance and Positioning

In recent market cycles, State Street SPDR S&P 500 ETF Trust (SPY) has delivered returns closely aligned with overall large-cap benchmarks due to its market-cap weighting. Virtus Terranova U.S. Quality Momentum ETF (JOET) has shown differentiated behavior tied to its factor exposures, with potential outperformance during periods when quality and momentum characteristics are rewarded. Relative positioning reflects JOET’s tilt toward stocks displaying improving fundamentals and price trends, which can result in higher volatility compared with SPY’s more diversified profile. Sector rotation and earnings delivery from top holdings continue to shape performance differentials across broader timeframes. From what I see, this factor sensitivity is worth monitoring closely in changing market regimes.

Tickeron AI Verdict

Tickeron’s AI would likely assign a higher probability to State Street SPDR S&P 500 ETF Trust (SPY) in a core allocation context. The combination of significantly lower expense ratio, broader diversification across 500 holdings, and market-cap weighting aligned with overall market trends supports more consistent long-term positioning. Virtus Terranova U.S. Quality Momentum ETF (JOET) may appeal in environments favoring momentum and quality factors, yet its higher cost and narrower selection introduce additional structural considerations.

Integrating AI Tools into My ETF Research

In my own process, I frequently use Tickeron’s AI Screener to compare ETFs like these side by side. It lets me apply filters for holdings, expense ratios, sector exposure, and performance patterns in one place, which helps highlight the structural differences without manual number-crunching. This approach keeps the analysis efficient and data-driven.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SPY, JOET

Contributor

Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.


SPY in upward trend: 10-day moving average crossed above 50-day moving average on August 05, 2026

The 10-day moving average for SPY crossed bullishly above the 50-day moving average on August 05, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 31, 2026. You may want to consider a long position or call options on SPY as a result. In of 74 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SPY just turned positive on August 03, 2026. Looking at past instances where SPY's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

SPY moved above its 50-day moving average on July 31, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SPY advanced for three days, in of 366 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for SPY moved out of overbought territory on August 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 46 similar instances where the indicator moved out of overbought territory. In of the 46 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SPY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SPY broke above its upper Bollinger Band on August 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for SPY entered a downward trend on July 08, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Apple (NASDAQ:AAPL), Alphabet (NASDAQ:GOOG), Alphabet (NASDAQ:GOOGL), Microsoft Corp (NASDAQ:MSFT), Amazon.com (NASDAQ:AMZN), Broadcom Inc. (NASDAQ:AVGO), Meta Platforms (NASDAQ:META), Tesla (NASDAQ:TSLA), Eli Lilly & Co (NYSE:LLY).

Industry description

The investment seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the S&P 500® Index. The trust seeks to achieve its investment objective by holding a portfolio of the common stocks that are included in the index (the “Portfolio”), with the weight of each stock in the Portfolio substantially corresponding to the weight of such stock in the index.

Market Cap

The average market capitalization across the State Street® SPDR® S&P 500® ETF ETF is 162.71B. The market cap for tickers in the group ranges from 5.02B to 5.27T. NVDA holds the highest valuation in this group at 5.27T. The lowest valued company is EPAM at 5.02B.

High and low price notable news

The average weekly price growth across all stocks in the State Street® SPDR® S&P 500® ETF ETF was 21%. For the same ETF, the average monthly price growth was 52%, and the average quarterly price growth was 298%. PLTR experienced the highest price growth at 39%, while DVA experienced the biggest fall at -21%.

Volume

The average weekly volume growth across all stocks in the State Street® SPDR® S&P 500® ETF ETF was -17%. For the same stocks of the ETF, the average monthly volume growth was 1% and the average quarterly volume growth was -45%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 51
Price Growth Rating: 41
SMR Rating: 50
Profit Risk Rating: 58
Seasonality Score: -31 (-100 ... +100)
View a ticker or compare two or three
SPY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Category LargeBlend

Profile
Details
Category
Large Blend
Address
PDR Services, 86 Trinity PlaceNew York
Phone
N/A
Web
www.spdrs.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.